Harvard Pilgrim Implements Real-World Data-Driven Prior Authorization Solution That Leverages Both Clinical and Claims Data
ATLANTA, WELLESLEY – [October 13, 2020] – OncoHealth, the leading digital health company focused on the physical, mental and financial complexities of cancer care, providers, and patients with solutions that are purpose-built for oncology, has announced a multi-year partnership with Harvard Pilgrim Health Care, a leading not-for-profit health plan insuring 3 million members in New England and beyond.
Harvard Pilgrim’s selection of OncoHealth’s utilization management solution was based on its capacity to leverage both provider generated real-world data and health plan claims data in making evidence-based decisions quickly, as well as its analytics software, which normalizes data into novel dashboards to better manage trends in drug utilization, spend and population health of oncology members. The actionable insights gained will enable Harvard Pilgrim to make more informed cancer treatment decisions and better control their year-over-year trend on cancer drug spend. Over time, collaboration around real-world clinical and claims data will facilitate Harvard Pilgrim’s ability to participate in outcomes studies, which analyze the effects and impact of cancer drugs on specific patient cohorts.
“By partnering with OncoHealth, Harvard Pilgrim can now make faster, evidence-based cancer treatment decisions for our members using the latest in electronic prior authorization technology,” said Michael Sherman, M.D., chief medical officer and senior vice president for health services, Harvard Pilgrim Health Care. “OncoHealth’s dedication to oncology and data science has enabled Harvard Pilgrim to significantly improve our prior authorization service for providers while gaining a better understanding of evidence-based prescribing patterns for our members undergoing cancer treatment.”
“OncoHealth has deep respect and admiration for Harvard Pilgrim’s culture of innovation, specifically their pioneering work in driving value-based contracts with the pharmaceutical industry,” said Rick Dean, CEO, OncoHealth. “We are confident that our partnership, which prioritizes a collaborative relationship with Harvard Pilgrim’s network providers, supported by actionable insights based on real-world, evidence-driven data, will further underscore why Harvard Pilgrim is consistently viewed as a leader in the health plan market.”
About OncoHealth
OncoHealth is a leading digital health company dedicated to helping health plans, employers, providers, patients, and life science researchers navigate the physical, mental, and financial complexities of cancer through technology enabled services and real-world data analytics. Supporting more than 7 million people in the US and Puerto Rico, OncoHealth offers digital solutions for treatment review, real-world evidence, and virtual care across all cancer types. For more information, visit www.oncohealth.us
About Harvard Pilgrim Health Care
Harvard Pilgrim Health Care and its family of companies provide health benefit plans, programs, and services to more than 3 million customers in New England and beyond. A leading not-for-profit health services company, we guide our members – and the communities we serve – to better health. Founded by doctors over 50 years ago, we’re building on our legacy. In partnership with our network of more than 70,000 doctors and 182 hospitals, we’re improving health outcomes and lowering costs through clinical quality and innovative care management. Our commitment to the communities we serve is driven by the passion of the Harvard Pilgrim Health Care Foundation. Through its work, low- and moderate-income families are gaining greater access to fresh, affordable food—a cornerstone to better health and well-being. To learn more about Harvard Pilgrim, visit www.harvardpilgrim.org.
OncoHealth Media Contact
Jennifer Haas
jhaas@oncohealth.us
Harvard Pilgrim Health Care Media Contact
Phil Tracey
philip_tracey@harvardpilgrim.org